Following concerns involving imported food, drugs and ingredients, the U.S. House is considering a bill brought forth by Reps. John Dingell (D-Mich.), Bart Stupak (D-Mich.), and Frank Pallone (D-N.J.).

As introduced, the legislation would give the U.S. Food and Drug Administration stronger investigative powers. The bill, H.R. 758, is called the FDA Globalization Act and was introduced to the House last week. It would require that foreign factories producing drugs and medical devices be inspected at least every two years, which is the standard for companies producing such goods in the United States.

New fees on imports would help pay for the enhanced inspection requirements. The bill also would allow FDA officials to impose larger fines on companies for faulty imported and domestic products.